SCHEMBL3976495

SCHEMBL3976495

[CH2]c1cc(CO)cc(Cl)c1Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.37
HPGD P15428 7/20 0.33
HSD17B10 Q99714 6/20 0.33
TSHR P16473 5/20 0.33
CYP3A4 P08684 4/20 0.33
RECQL P46063 2/20 0.33
CRHBP P24387 1/20 0.33
CRHR2 Q13324 1/20 0.33
S1PR1 P21453 1/20 0.33
CASP1 P29466 1/20 0.33
HSP90AA1 P07900 2/20 0.31
MAPK1 P28482 2/20 0.31
THRB P10828 2/20 0.31
NPC1 O15118 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
MEN1 O00255 1/20 0.31
USP2 O75604 1/20 0.31
EGFR P00533 1/20 0.31
LMNA P02545 1/20 0.31
ESR1 P03372 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1965439 0.83 HPGD (0.48) ACHEHPGDHSD17B10TSHRCYP3A4
SCHEMBL7595073 0.74 KDM4E (0.43) ACHEHPGDHSD17B10TSHRCYP3A4
SCHEMBL17414230 0.73 ACHE (0.37) ACHEHPGDHSD17B10TSHRCYP3A4
SCHEMBL670342 0.70 ACHE (0.43) ACHEHPGDHSD17B10TSHRCYP3A4
SCHEMBL522619 0.70 ACHE (0.43) ACHEHPGDHSD17B10TSHRCYP3A4
SCHEMBL737479 0.70 HSD17B10 (0.52) ACHEHPGDHSD17B10TSHRCYP3A4
SCHEMBL23588139 0.69 ACHE (0.42) ACHEHPGDTSHRRECQLS1PR1
SCHEMBL1964510 0.69 ALDH1A1 (0.50) ACHETSHRCYP3A4RECQLTHRB
SCHEMBL13116413 0.69 ACHE (0.42) ACHEHPGDTSHRCYP3A4RECQL
SCHEMBL11981468 0.69 ACHE (0.42) ACHEHPGDTSHRRECQLS1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 ACHE 1893/4885HPGD 299/4885HSD17B10 683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.